10176-71-3

Basic information

• Product Name: Scutellarein 4',7- dimethyl ether
• Synonyms: 4',7-Dimethoxy-5,6-dihydroxyflavone;5,6-Dihydroxy-4',7-dimethoxyflavone;Ladanein;Scutellarein 4',7- dimethyl ether;5,6-Dihydroxy-7,4'-dimethoxyflavone;BJ 486K;Ladanine;5,6-DIHYDROXY-7-METHOXY-2-(4-METHOXYPHENYL)-4H-CHROMEN-4-ONE
• CAS NO: 10176-71-3
• Molecular Formula: C₁₇H₁₄O₆
• Molecular Weight: 314.28946
• Mol File: 10176-71-3.mol
• Article Data: 6

Chemical Properties

• Melting Point: 310-313℃
• Boiling Point: 565.7°C at 760 mmHg
• Flash Point: 212.4°C
• Appearance: /
• Density: 1.402g/cm³
• Vapor Pressure: 2.11E-13mmHg at 25°C
• Refractive Index: 1.645
• CAS DataBase Reference: Scutellarein 4',7- dimethyl ether(CAS DataBase Reference)
• NIST Chemistry Reference: Scutellarein 4',7- dimethyl ether(10176-71-3)
• EPA Substance Registry System: Scutellarein 4',7- dimethyl ether(10176-71-3)

Safety Data

• Hazardous Substances Data: 10176-71-3(Hazardous Substances Data)

Usage

General Description

Scutellarein 4',7-dimethyl ether is a natural flavonoid compound found in various plant species, including Scutellaria lateriflora and Scutellaria baicalensis. It is known for its potential health benefits, including antioxidant, anti-inflammatory, and neuroprotective properties. Studies have also suggested that scutellarein 4',7-dimethyl ether may have anti-cancer effects by inhibiting the growth of cancer cells and inducing apoptosis. Additionally, it has been investigated for its potential therapeutic effects on various conditions, such as cardiovascular diseases, diabetes, and neurodegenerative disorders. Overall, scutellarein 4',7-dimethyl ether is a promising natural compound with potential pharmaceutical applications for various health conditions.

InChI:InChI=1/C17H14O6/c1-21-10-5-3-9(4-6-10)12-7-11(18)15-13(23-12)8-14(22-2)16(19)17(15)20/h3-8,19-20H,1-2H3

Upstream product

• 6563-66-2 5,6,7-trihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one 
• 74-88-4 methyl iodide 
• 7702-17-2 4-(acetyloxy)-3,5-dimethoxyphenyl acetate 
• 530-55-2 2,6-dimethoxy-p-quinone 
• 6962-57-8 3,6-dihydroxy-2,4-dimethoxyacetophenone 
• 90-24-4 2-hydroxy-4,6-dimethoxyacetophenone 
• 6938-19-8 6-hydroxy-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one 
• 10176-70-2 5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-6-yl 4-methoxybenzoate 
• 10176-68-8 4-hydroxy-2,6-dimethoxy-3-(3-(4-methoxyphenyl)-3-oxopropanoyl)phenyl 4-methoxybenzoate 
• 1311993-73-3 5,6-dihydroxy-7,4'-dimethoxyflavone-6-O-α-D-rhamnosyl-(1->6)-β-D-glucose 
• 98452-84-7 Acetic acid 5,7-dimethoxy-2-(4-methoxy-phenyl)-4-oxo-4H-chromen-6-yl ester 
• 794-94-5 p-Methoxybenzoic anhydride 

Downstream Products

• 1456770-94-7 C₁₈H₁₄O₆ 
• 197908-15-9 Toluene-4-sulfonic acid 6-hydroxy-7-methoxy-2-(4-methoxy-phenyl)-4-oxo-4H-chromen-5-yl ester 

Relevant articles and documents

Chemical constituents of the leaves of glochidion obliquum and their bioactivity

A new flavonoid glycoside, globlin A (1), and eleven known compounds were isolated from methanolic extracts of the leaves of Glochidion obliquum. The structure of this new compound was established with a combination of 2D NMR techniques (COSY, NOESY, HMQC

A practical and economical high-yielding, six-step sequence synthesis of a flavone: Application to the multigram-scale synthesis of ladanein

Herein we report a short and economic synthesis of the antiviral flavonoid lead ladanein (1). Ladanein is obtained from 2,6-dimethoxyquinone (11) in six steps with 51% overall yield. After a high-yielding reductive acetylation and Fries rearrangement, the

FLAVONE DERIVATIVES AND THEIR USE

The present invention relates to flavone derivatives and to compositions containing one or more of these flavone derivatives. The present invention further relates to fiavone derivatives or compositions for use in the treatment and/or prevention of a vira